Advisory Boards

ViewRay draws on experience of industry leaders


ViewRay Vision

 

In this four-minute video, members of ViewRay's Scientific and Clinical Advisory Boards talk about the need for—and the potential of—the MRIdian system. "We believe this could be a paradigm changer in our field," says Sasa Mutic, PhD, professor of radiation oncology at Washington University.

Board of Directors

Chris A. Raanes, ViewRay Incorporated

James Dempsey, PhD, ViewRay Incorporated

Josh Bilenker, MD, Aisling Capital

David Bonita, MD, OrbiMed Advisors

Caley Castelein, MD, Kearny Venture Partners

Mark Gold, MD, University of Florida College of Medicine

Aditya Puri, Xeraya Capital

 

Scientific Advisory Board

Patrick Kupelian, MD, University of California, Los Angeles

David Larson, MD, PhD, University of California, San Francisco

Dan Low, PhD, University of California, Los Angeles

Bhudatt Paliwal, PhD, University of Wisconsin, Madison

Carlos A. Perez, MD, Washington University, St. Louis, Missouri 

Theodore L. Phillips, MD, University of California, San Francisco; University of California, Davis; University of Arizona, Tucson

James A. Purdy, PhD, University of California, Davis

Christopher M. Rose, MD, Valley Radiotherapy Associates Medical Group, Beverly Hills, California

Wolfgang A. Tomé, PhD, FAAPM, Yeshiva University and Montefiore Medical Center, New York, New York

 

Clinical trials Advisory Board

Minesh Mehta, MD, Northwestern University, Chicago, Illinois

William Mendenhall, MD, University of Florida, Gainesville

Copyright 2015 © ViewRay. All rights reserved - KMCreative